文献速递脑血管病认知障碍与痴呆

脑血管病理的可溶性生物标志物

Soluble Biomarkers of Cerebrovascular Pathologies.
PubMed 文献 · Stroke · 2024-03-25

本文综述了血管性认知障碍与痴呆(VCID)血液生物标志物的研究现状,指出VCID异质性强且常与阿尔茨海默病共存,重点介绍了辅助寻找敏感且特异的脑血管功能障碍血液标志物的路径、有前景的候选标志物及正在进行的发现计划。

要点

  • VCID是涵盖脑血管起源认知障碍的总称,常与阿尔茨海默病共存。
  • 阿尔茨海默病血液标志物已研究多年,VCID血液标志物仍处于起步阶段并面临挑战。
  • VCID具有异质性,包括缺血性或出血性病理实体及急性或慢性时空差异。

核心结论

  • VCID血液生物标志物研究仍处于起步阶段并面临挑战,本综述重点介绍了辅助寻找敏感且特异的脑血管功能障碍血液标志物的路径、有前景的候选标志物及正在进行的发现计划。

研究设计与样本

  • 综述,检索范围未在原文中报告。

主要发现

  • VCID常与阿尔茨海默病共存。
  • VCID具有异质性,包括缺血性或出血性等不同病理实体以及急性或慢性等时空差异。
  • 阿尔茨海默病领域已多年致力于建立和检验用于诊断、预后、临床治疗发现和早期检测的血液生物标志物,而VCID血液生物标志物仍处于起步阶段。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vascular contributions to cognitive impairment and dementia (VCID) is an all-encompassing term that describes cognitive impairment due to cerebrovascular origins. With the advancement of imaging and pathological studies, we now understand that VCID is often comorbid with Alzheimer disease. While researchers in the Alzheimer disease field have been working for years to establish and test blood-based biomarkers for Alzheimer disease diagnosis, prognosis, clinical therapy discovery, and early detection, blood-based biomarkers for VCID are in their infancy and also face challenges. VCID is heterogeneous, comprising many different pathological entities (ischemic, or hemorrhagic), and spatial and temporal differences (acute or chronic). This review highlights pathways that are aiding the search for sensitive and specific blood-based cerebrovascular dysfunction markers, describes promising candidates, and explains ongoing initiatives to discover blood-based VCID biomarkers.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Foley KE, Wilcock DM. Soluble Biomarkers of Cerebrovascular Pathologies. Stroke. 2024. PMID: 38527143. doi:10.1161/STROKEAHA.123.044172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。